The Efficacy and Safety of aobetasolpropionate Compound Ointment, in Patients with Psoriasis Vulgaris
Qifeng Chen
Abstract
Qifeng Chen
Abstract
Objective To assess the efficacy and safety of clobetasolpropionate compound ointment(0.05% clobetasol propi-onate and 0.025 % tretinoin) in patients with psoriasis vulgaris. Methods Randomized,double-blindness and positive drug parallel comparison trial. Trial group, control groupl and control group2 were respectively given clobetasolpropionate Compound,0. 05 % clobetasol propionate and 0. 025% tretinoin. To observe the change of symptom and sign in every patient and to analyse every group's data. Results There were significant differences of efficacy among trial group and ochers(P0.05) and no adverse effects in all groups. Conclusion Clobetasol propionate Compound is an effective and safe drug in treatment of patients with psoriasis vulgaris.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To assess the efficacy and safety of clobetasolpropionate compound ointment(0.05% clobetasol propi-onate and 0.025 % tretinoin) in patients with psoriasis vulgaris. Methods Randomized,double-blindness and positive drug parallel comparison trial. Trial group, control groupl and control group2 were respectively given clobetasolpropionate Compound,0. 05 % clobetasol propionate and 0. 025% tretinoin. To observe the change of symptom and sign in every patient and to analyse every group's data. Results There were significant differences of efficacy among trial group and ochers(P0.05) and no adverse effects in all groups. Conclusion Clobetasol propionate Compound is an effective and safe drug in treatment of patients with psoriasis vulgaris.
Key concepts: Clobetasol propionate, Psoriasis, Medicine, Dermatology, Adverse effect, Drug, Tretinoin, Internal medicine